Hereditary Cancer Panels

Selecta Lab’s cancer genomics testing analyzes mutations in a patient’s DNA known to be associated with an increased risk of hereditary cancer. Selecta Labs provides a comprehensive report indicating a patient’s potential susceptibility to various hereditary cancers. This testing uses the latest next generation sequencing technology to analyze patient samples in a rapid and accurate fashion.

This information helps guide a clinician’s route of personalized therapy dependent on the specific genomic mutation and associated cancer. Currently, Selecta Labs offers the analysis of thirtyseven (37) genes covering eighteen (18) different cancers as shown below:

**Click on the Gene to learn more about it**

Gene(s) Associated Cancer(s)/Tumor(s)
APC Colorectal, central nervous system, thyroid, liver, duodenal, pancreatic
ATM Breast, pancreatic
NBN Breast, prostate, possibly ovarian
BRCA1, BRCA2 Breast, ovarian, prostate, pancreatic, male breast
BRIP1, RAD51C,
RAD51D
Breast, ovarian
BMPR1A, SMAD4 Stomach, colorectal, pancreatic
CDH1 Breast, colorectal, gastric
CDK4 Melanoma
CDKN2A Melanoma, pancreatic
CHEK2 Breast, colorectal
FH Kidney, leiomyomas
FLCN Kidney
MAX Pheochromocytoma
MLH1, MSH2,
MSH6, PMS2,
EPCAM
Ovarian, colorectal, uterine, stomach, small bowel, hepatobiliary, brain,
pancreatic, sebaceous, urinary tract
MUTYH Breast, colorectal
NF1 Optic glioma, gastrointestinal stromal tumor,
paraganglioma/pheochromocytoma, neurofibromas, breast, Central
nervous system
PALB2 Breast, pancreatic
PTEN Breast, uterine, thyroid, colorectal, kidney
RET Thyroid (medullary), Pheochromocytoma
SDHAF2, SDHB,
SDHC, SDHD
Kidney, paraganglioma/pheochromocytoma, gastrointestinal stromal
tumor
TSC1, TSC2 Kidney, cardiac rhabdomyomas, central nervous system
STK11 Colorectal, small bowel, pancreatic, breast, ovarian
TMEM127 Paraganglioma/pheochromocytoma
TP53 Brain, leukemia, breast, sarcoma, adrenocortical, gastrointestinal,
genitourinary
VHL Kidney, pheochromocytoma, central nervous system